Poly Medicure Ltd Analyst Rating
based on 6 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 6 analysts offering long term price targets for Poly Medicure Ltd. An average target of ₹2215.5
Source: S&P Global Market Intelligence
Poly Medicure Ltd Share analysis
Poly Medicure Ltd price forecast by 6 analysts
Downside of
High
₹2500
Target
₹2215.50
Low
₹1999
Poly Medicure Ltd target price ₹2215.5, a slight downside of -9.66% compared to current price of ₹2450.55. According to 6 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Poly Medicure Ltd revenue growth forecast
Expected growth rate Q1, FY2026:50.57%
Forecast
Actual
Including amortisation and stock based compensations
Poly Medicure Ltd EPS growth forecast
EPS estimate Q1, FY2026:64.33%
Forecast
Actual
Source: S&P Global Market Intelligence
Poly Medicure Ltd Performance
Day's Low
Day's High
₹2,430₹2,495.9552 Week's Low
52 Week's High
₹1,250.1₹2,686.6
| Returns % | |
| 1 Month Return | + 3.96 % |
| 3 Month Return | + 19.92 % |
| 1 Year Return | + 88.06 % |
| Market Stats | |
| Previous Close | ₹2,452.50 |
| Open | ₹2,473.35 |
| Volume | 48.05K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹24,841.51Cr |
Poly Medicure Ltd Key Statistics
| P/E Ratio | 87.31 |
| PEG Ratio | 15.37 |
| Market Cap | ₹24,841.51 Cr |
| P/B Ratio | 10.46 |
| EPS | 26.91 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 18.7 |
Poly Medicure Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹24,841.51 Cr | 215.87% | 0.55 | ₹258 Cr | ₹1,375 Cr | |
| HOLD | ₹31,560.96 Cr | 127.13% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹18,791.82 Cr | 30.25% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹6,996.36 Cr | 12.52% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹14,535.09 Cr | 43.59% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Poly Medicure Ltd Mutual Fund Holdings
About Poly Medicure Ltd
Poly Medicure Ltd is well-known for its top-notch medical devices, which include disposable syringes, infusion sets, blood transfusion sets, and medical gloves. The company also manufactures a wide range of pharmaceuticals, ranging from antibiotics to painkillers. Its diagnostics services include X-ray, ultrasound, and CT scan.
Poly Medicure Ltd has several popular brands in its portfolio, including Polymed, Polycare, PolyPlus, and PolymedPlus. These brands are renowned for their quality and reliability. The company has also developed a wide range of innovative products, such as the Polymed Plus, which is a multi-purpose medical device that can be used for a variety of medical procedures.
Share Price: ₹2450.55 per share as on 21 Oct, 2024 04:01 PM
Market Capitalisation: ₹24,841.51Cr as of today
Revenue: ₹384.78Cr as on June 2024 (Q2 24)
Net Profit: ₹74.04Cr as on June 2024 (Q2 24)
Listing date: 07 Dec, 2011
Chairperson Name: Devendra Raj Mehta
| Organisation | Poly Medicure Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Poly Medicure Ltd
Poly Medicure Plans Strategic Growth and Expansion - 15 Oct, 2024
Poly Medicure's MD, Himanshu Baid, outlines strategic priorities for FY25, including a Rs. 500 crore investment in manufacturing, new product introductions, and market expansion in Europe, the US, and Latin America.
Poly Medicure Plans Major Expansion with ₹500 Crore Investment - 13 Oct, 2024
Poly Medicure Ltd. is investing over ₹500 crore to expand in cardiology, critical care, and renal care, targeting global markets. The company aims for 22-24% revenue growth in FY25, supported by a ₹1,000 crore QIP. Plans include new facilities and strategic acquisitions to enhance innovation and market share, particularly in Europe and the US.
Poly Medicure Plans Acquisitions and Expansion - 16 Sep, 2024
Poly Medicure aims for technology acquisitions and capital expenditure after raising Rs 1,000 crore through QIP. Rs 250 crore is allocated for acquisitions, with plans for product expansion and increased global reach.
Insights on Poly Medicure Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 11.10% to 11.86% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 9 quarters, 253.82 Cr → 402.13 Cr (in ₹), with an average increase of 5.5% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 7.24% to 7.35% in Sep 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 62.19 Cr → 74.04 Cr (in ₹), with an average increase of 5.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, POLYMED stock has moved up by 2.7%
NO EFFECTAgainst Peers
In the last 1 year, One Global Service Provider Ltd has given 202.4% return, outperforming this stock by 114.3%
- NO EFFECT
Against Peers
In the last 3 years, One Global Service Provider Ltd has given 543.2% return, outperforming this stock by 380.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 62.56% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 13.87% to 13.24% in Sep 2024 quarter
Poly Medicure Ltd Financials
Index Inclusions
Poly Medicure Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 62.56% | 0.00 | |
| Foreign Institutions | 11.86% | 6.83 | |
| Mutual Funds | 7.35% | 1.49 | |
| Retail Investors | 13.24% | ||
| Others | 5% |
Poly Medicure Ltd Key Indicators
Poly Medicure Ltd Valuation
Poly Medicure Ltd in the last 5 years
Lowest (18.90x)
March 24, 2020
Today (87.31x)
October 18, 2024
Industry (95.46x)
October 18, 2024
Highest (91.51x)
September 5, 2024
Poly Medicure Ltd Earnings and Dividends
Poly Medicure Ltd Earnings Results
Poly Medicure Ltd’s net profit jumped 18.09% since last year same period to ₹74.04Cr in the Q1 2024-2025. On a quarterly growth basis, Poly Medicure Ltd has generated 8.31% jump in its net profits since last 3-months.
Read More about Earnings ResultsPoly Medicure Ltd Dividends May,2024
In the quarter ending March 2024, Poly Medicure Ltd has declared dividend of ₹3 - translating a dividend yield of 0.12%.
Read More about Dividends
Poly Medicure Ltd Technicals Summary
Bearish
Neutral
Bullish
Poly Medicure Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Poly Medicure Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Poly Medicure Ltd shares.
Poly Medicure Ltd (POLYMED) share price today is ₹2450.55
Poly Medicure Ltd is listed on NSE
Poly Medicure Ltd is listed on BSE
- Today’s highest price of Poly Medicure Ltd is ₹2495.95.
- Today’s lowest price of Poly Medicure Ltd is ₹2430.
PE Ratio of Poly Medicure Ltd is 87.31
PE ratio = Poly Medicure Ltd Market price per share / Poly Medicure Ltd Earnings per share
Today’s traded volume of Poly Medicure Ltd(POLYMED) is 48.05K.
Today’s market capitalisation of Poly Medicure Ltd(POLYMED) is ₹24841.51Cr.
| Poly Medicure Ltd(POLYMED | Price |
|---|---|
52 Week High | ₹2686.6 |
52 Week Low | ₹1250.1 |
Poly Medicure Ltd(POLYMED) share price is ₹2450.55. It is down -8.79% from its 52 Week High price of ₹2686.6
Poly Medicure Ltd(POLYMED) share price is ₹2450.55. It is up 96.03% from its 52 Week Low price of ₹1250.1
| Poly Medicure Ltd(POLYMED | Returns |
|---|---|
1 Day Returns | -1.95% |
1 Month Returns | 3.96% |
3 Month Returns | 19.92% |
1 Year Returns | 88.06% |